AXIO Group, which manages a global portfolio of market-leading information businesses has announced it has received a binding offer from M3, Inc. to purchase Vidal Group (‘Vidal’), a leading European provider of reference drug information for healthcare professionals, for €100 million
B2B B2C Exhibitions Events Digital Publishing MarComms